Zacks Research Has Positive Outlook for PAHC FY2025 Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Zacks Research raised their FY2025 earnings per share (EPS) estimates for shares of Phibro Animal Health in a research report issued to clients and investors on Tuesday, December 10th. Zacks Research analyst R. Department now anticipates that the company will earn $1.47 per share for the year, up from their prior forecast of $1.46. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.61 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q4 2025 earnings at $0.42 EPS, Q1 2026 earnings at $0.30 EPS, FY2026 earnings at $1.61 EPS, Q1 2027 earnings at $0.47 EPS and FY2027 earnings at $2.11 EPS.

Several other equities research analysts have also recently commented on PAHC. StockNews.com cut shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Friday, December 6th. Barclays boosted their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a research note on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price objective on the stock. Finally, Bank of America boosted their price target on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th.

Phibro Animal Health Price Performance

NASDAQ PAHC opened at $23.88 on Thursday. Phibro Animal Health has a 12-month low of $10.03 and a 12-month high of $25.98. The firm’s 50 day moving average is $23.58 and its 200-day moving average is $20.52. The company has a market capitalization of $967.21 million, a PE ratio of 55.53, a price-to-earnings-growth ratio of 0.60 and a beta of 0.51. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th will be paid a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.01%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 111.63%.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. CWM LLC increased its position in Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares in the last quarter. nVerses Capital LLC acquired a new position in Phibro Animal Health in the third quarter valued at $70,000. Quantbot Technologies LP acquired a new stake in Phibro Animal Health during the third quarter worth approximately $70,000. Summit Securities Group LLC acquired a new stake in shares of Phibro Animal Health during the 2nd quarter worth approximately $83,000. Finally, China Universal Asset Management Co. Ltd. raised its holdings in shares of Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares during the period. 99.34% of the stock is owned by institutional investors.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.